CoChat
Sign Up
Cited by 205

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Multiple sclerosis and cognition: synaptic failure and network dysfunction

Di Filippo, Massimiliano, Portaccio, Emilio, Mancini, Andrea, Calabresi, Paolo·2018·Nature Reviews Neuroscience
DOI 10.1038/s41583-018-0053-9
Open this paper in CoChat — free account

Abstract

Cognitive impairment is increasingly recognized to be a core feature of multiple sclerosis (MS), with important implications for the everyday life of individuals with MS and for disease management. Unfortunately, the exact mechanisms that underlie this cognitive impairment are poorly understood and there are no effective therapeutic options for this aspect of the disease. During MS, focal brain inflammatory lesions, together with pathological changes of both CNS grey matter and normal-appearing white matter, can interfere with cognitive functions. Moreover, inflammation may alter the crosstalk between the immune and the nervous systems, modulating the induction of synaptic plasticity and neurotransmission. In this Review, we examine the CNS structures and cognitive domains that are affected by the disease, with a specific focus on hippocampal involvement in MS and experimental autoimmune encephalomyelitis, an experimental model of MS. We also discuss the hypothesis that, during MS, immune-mediated alterations of synapses' ability to express long-term plastic changes may contribute to the pathogenesis of cognitive impairment by interfering with the dynamics of neuronal networks.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41583-018-0053-9

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 11 references

Research works printed but not linked: 138

  1. Comi, G., Radaelli, M. & Soelberg Sørensen, P. Evolving concepts in the treatment of relapsing multiple sclerosis. Lancet 389, 1347–1356 (2017). · DOI
  2. Filippi, M. et al. Attendees of the correlation between pathological MRI findings in MS workshop. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol. 11, 349–360 (2012). · DOI
  3. Charcot, J. M. Lectures on diseases of the nervous system (London: New Sydenham Society, 1877).
  4. Chiaravalloti, N. D. & DeLuca, J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 7, 1139–1151 (2008). · DOI · Paper page
  5. Langdon, D. W. Cognition in multiple sclerosis. Curr. Opin. Neurol. 24, 244–249 (2011). · DOI
  6. DeLuca, G. C., Yates, R. L., Beale, H. & Morrow, S. A. Cognitive impairment in multiple sclerosis: clinical, radiologic and pathologic insights. Brain Pathol. 25, 79–98 (2015). · DOI
  7. Di Filippo, M., Sarchielli, P., Picconi, B. & Calabresi, P. Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders. Trends Pharmacol. Sci. 29, 402–412 (2008). · DOI
  8. Rocca, M. A. et al. Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol. 14, 302–317 (2015). This paper presents an elegant review on both clinical and neuroimaging aspects of cognitive impairment in MS. · DOI · Paper page
  9. Amato, M. P. et al. Association of MRI metrics and cognitive impairment in radiologically isolated syndromes. Neurology 78, 309–314 (2012). · DOI
  10. Ruano, L. et al. Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes. Mult Scler. 23, 1258–1267 (2017). · DOI · Paper page
  11. Goldschmidt, T., Antel, J., König, F. B., Brück, W. & Kuhlmann, T. Remyelination capacity of the MS brain decreases with disease chronicity. Neurology 72, 1914–1921 (2009). · DOI · Paper page
  12. Achiron, A. et al. Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves. J. Neurol. Neurosurg. Psychiatry 76, 744–749 (2005). · DOI
  13. Deloire, M., Ruet, A., Hamel, D., Bonnet, M. & Brochet, B. Early cognitive impairment in multiple sclerosis predicts disability outcome several years later. Mult. Scler. 16, 581–587 (2010). · DOI
  14. Moccia, M. et al. Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression. Mult. Scler. 22, 659–667 (2016). · DOI
  15. Zipoli, V. et al. Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Mult. Scler. 16, 62–67 (2010). · DOI
  16. Morrow, S. A. et al. On-road assessment of fitness-to-drive in persons with MS with cognitive impairment: a prospective study. Mult. Scler. https://doi.org/10.1177/1352458517723991 (2017). · DOI
  17. Schultheis, M. T. et al. Examining the relationship between cognition and driving performance in multiple sclerosis. Arch. Phys. Med. Rehabil. 91, 465–473 (2010). · DOI
  18. Morrow, S. A. et al. Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline. Clin. Neuropsychol. 24, 1131–1145 (2010). · DOI
  19. Rao, S. M., Leo, G. J., Bernardin, L. & Unverzagt, F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41, 685–691 (1991). · DOI
  20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn (American Psychiatric Association, 2013). · DOI · Paper page
  21. Cotter, J. et al. Social cognition in multiple sclerosis: a systematic review and meta-analysis. Neurology 87, 1727–1736 (2016). · DOI
  22. Dineen, R. A. et al. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain 132, 239–249 (2009). This study investigates the possibility that cognitive dysfunction in MS is related to the disconnection of cognitively important processing regions by white matter damage. · DOI
  23. Preziosa, P. et al. Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: a multicenter study. Hum. Brain Mapp. 37, 1627–1644 (2016). · DOI
  24. Calabrese, M. et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch. Neurol. 66, 1144–1150 (2009). · DOI
  25. Harrison, D. M. et al. Association of cortical lesion burden on 7-T magnetic resonance imaging with cognition and disability in multiple sclerosis. JAMA Neurol. 72, 1004–1012 (2015). · DOI
  26. Preziosa, P. et al. DT MRI microstructural cortical lesion damage does not explain cognitive impairment in MS. Mult. Scler. 23, 1918–1928 (2017). · DOI
  27. Bellmann-Strobl, J. et al. Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis. Neurology 73, 1624–1627 (2009). This study shows that the performance of individuals with MS on the PASAT is affected by the appearance of MRI contrast-enhancing lesions, surrogate markers of CNS inflammatory activity. · DOI
  28. Pardini, M. et al. Isolated cognitive relapses in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 85, 1035–1037 (2014). · DOI
  29. Mori, F. et al. Early treatment with high-dose interferon beta-1a reverses cognitive and cortical plasticity deficits in multiple sclerosis. Funct. Neurol. 27, 163–168 (2012).
  30. Heesen, C. et al. Correlates of cognitive dysfunction in multiple sclerosis. Brain Behav. Immun. 24, 1148–1155 (2010). · DOI
  31. Bonnier, G. et al. Multicontrast MRI quantification of focal inflammation and degeneration in multiple sclerosis. Biomed. Res. Int. 2015, 569123 (2015). · DOI
  32. Steenwijk, M. D. et al. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant. Brain 139, 115–126 (2016). · DOI
  33. Bergsland, N., Zivadinov, R., Dwyer, M. G., Weinstock-Guttman, B. & Benedict, R. H. Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients. Mult. Scler. 22, 1327–1336 (2016). · DOI
  34. Batista, S. et al. Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J. Neurol. 259, 139–146 (2012). · DOI
  35. Planche, V. et al. Regional hippocampal vulnerability in early multiple sclerosis: dynamic pathological spreading from dentate gyrus to CA1. Hum. Brain Mapp. 39, 1814–1824 (2018). · DOI
  36. Cocozza, S. et al. Cerebellar lobule atrophy and disability in progressive MS. J. Neurol. Neurosurg. Psychiatry 88, 1065–1072 (2017). · DOI
  37. Granberg, T. et al. Corpus callosum atrophy is strongly associated with cognitive impairment in multiple sclerosis: results of a 17-year longitudinal study. Mult. Scler. 21, 1151–1158 (2015). · DOI
  38. Batista, S. et al. Impairment of social cognition in multiple sclerosis: amygdala atrophy is the main predictor. Mult. Scler. 23, 1358–1366 (2017). · DOI
  39. Batista, S. et al. Disconnection as a mechanism for social cognition impairment in multiple sclerosis. Neurology 89, 38–45 (2017). · DOI
  40. Eftekhari, E. et al. Normal appearing white matter permeability: a marker of inflammation and information processing speed deficit among relapsing remitting multiple sclerosis patients. Neuroradiology 59, 771–780 (2017). · DOI
  41. Filippi, M. et al. The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology 75, 2121–2128 (2010). · DOI
  42. Muhlert, N. et al. Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions. J. Neurol. Neurosurg. Psychiatry 85, 833–839 (2014). · DOI
  43. Pellicano, C. et al. Cognitive impairment and its relation to imaging measures in multiple sclerosis: a study using a computerized battery. J. Neuroimag. 23, 445–452 (2013). · DOI
  44. Sicotte, N. L. et al. Regional hippocampal atrophy in multiple sclerosis. Brain 131, 1134–1141 (2008). This study demonstrates that individuals with MS present with hippocampal atrophy and that hippocampal volume loss is associated with poor performance on word-list learning. · DOI
  45. Benedict, R. H., Ramasamy, D., Munschauer, F., Weinstock-Guttman, B. & Zivadinov, R. Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy. J. Neurol. Neurosurg. Psychiatry 80, 201–206 (2009). · DOI
  46. Debernard, L. et al. Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis. Psychiatry Res. 234, 352–361 (2015). · DOI
  47. González Torre, J. A. et al. Hippocampal dysfunction is associated with memory impairment in multiple sclerosis: a volumetric and functional connectivity study. Mult. Scler. 23, 1854–1863 (2017). · DOI
  48. Hulst, H. E. et al. Functional adaptive changes within the hippocampal memory system of patients with multiple sclerosis. Hum. Brain Mapp. 33, 2268–2280 (2012). · DOI
  49. Hulst, H. E. et al. Memory impairment in multiple sclerosis: relevance of hippocampal activation and hippocampal connectivity. Mult. Scler. 21, 1705–1712 (2015). · DOI
  50. Koenig, K. A. et al. Hippocampal volume is related to cognitive decline and fornicial diffusion measures in multiple sclerosis. Magn. Reson. Imaging 32, 354–358 (2014). · DOI
  51. Longoni, G. et al. Deficits in memory and visuospatial learning correlate with regional hippocampal atrophy in MS. Brain Struct. Funct. 220, 435–444 (2015). · DOI
  52. Planche, V. et al. Hippocampal microstructural damage correlates with memory impairment in clinically isolated syndrome suggestive of multiple sclerosis. Mult. Scler. 23, 1214–1224 (2016). · DOI · Paper page
  53. Sumowski, J. F. et al. Mesial temporal lobe and subcortical grey matter volumes differentially predict memory across stages of multiple sclerosis. Mult. Scler. 24, 675–678 (2017). · DOI
  54. Sacco, R. et al. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus. J. Neurol. 262, 1691–1697 (2015). · DOI
  55. Cawley, N. et al. Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis. Brain 138, 2584–2595 (2015). · DOI
  56. Rahn, K. A. et al. Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis. Proc. Natl Acad. Sci. USA 109, 20101–20106 (2012). · DOI
  57. Papadopoulos, D. et al. Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis. Brain Pathol. 19, 238–253 (2009). · DOI · Paper page
  58. Dutta, R. et al. Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients. Ann. Neurol. 69, 445–454 (2011). This study demonstrates that demyelinated hippocampi in MS show marked decreases in synaptic density and in the levels of neuronal proteins known to be important for learning and memory processes, such as those involved in glutamate neurotransmission and synaptic plasticity. · DOI
  59. Michailidou, I. et al. Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus. Ann. Neurol. 77, 1007–1026 (2015). · DOI
  60. Colasanti, A. et al. Hippocampal neuroinflammation, functional connectivity, and depressive symptoms in multiple sclerosis. Biol. Psychiatry 80, 62–72 (2016). · DOI
  61. Herranz, E. et al. Neuroinflammatory component of gray matter pathology in multiple sclerosis. Ann. Neurol. 80, 776–790 (2016). · DOI
  62. Dutra, R. C. et al. Spatial reference memory deficits precede motor dysfunction in an experimental autoimmune encephalomyelitis model: the role of kallikrein-kinin system. Brain Behav. Immun. 33, 90–101 (2013). · DOI
  63. Assini, F. L., Duzzioni, M. & Takahashi, R. N. Object location memory in mice: pharmacological validation and further evidence of hippocampal CA1 participation. Behav. Brain Res. 204, 206–211 (2009). · DOI · Paper page
  64. Acharjee, S. et al. Altered cognitive-emotional behavior in early experimental autoimmune encephalitis — cytokine and hormonal correlates. Brain Behav. Immun. 33, 164–172 (2013). · DOI
  65. D’Intino, G. et al. Cognitive deficit associated with cholinergic and nerve growth factor down-regulation in experimental allergic encephalomyelitis in rats. Proc. Natl Acad. Sci. USA 102, 3070–3075 (2005). · DOI
  66. Di Filippo, M. et al. Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis. Sci. Rep. 6, 20926 (2016).
  67. Lemon, N. & Manahan-Vaughan, D. Dopamine D1/D5 receptors gate the acquisition of novel information through hippocampal long-term potentiation and long-term depression. J. Neurosci. 26, 7723–7729 (2006). · DOI
  68. Ziehn, M. O. et al. Therapeutic testosterone administration preserves excitatory synaptic transmission in the hippocampus during autoimmune demyelinating disease. J. Neurosci. 32, 12312–12324 (2012). · DOI
  69. Titley, H. K., Brunel, N. & Hansel, C. Toward a neurocentric view of learning. Neuron 95, 19–32 (2017). This recent work integrates the synaptic and neuronal mechanisms of learning. · DOI
  70. Bliss, T. V. & Lomo, T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the performant path. J. Physiol. 232, 331–356 (1973). This article presents the first description of LTP, now recognized as a neurobiological model of memory processes. · DOI · Paper page
  71. Bliss, T. V. & Collingridge, G. L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31–39 (1993). · DOI · Paper page
  72. Nicoll, R. A. A. Brief history of long-term potentiation. Neuron 93, 281–290 (2017). · DOI · Paper page
  73. Malenka, R. C. & Bear, M. F. LTP and LTD: an embarrassment of riches. Neuron 44, 5–21 (2004). · DOI · Paper page
  74. Yirmiya, R. & Goshen, I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun. 25, 181–213 (2011). · DOI · Paper page
  75. Brambilla, R. et al. Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination. Glia 62, 452–467 (2014). · DOI
  76. Liddelow, S. A. & Barres, B. A. Reactive astrocytes: production, function, and therapeutic potential. Immunity 46, 957–967 (2017). · DOI · Paper page
  77. Lloyd, A. F., Davies, C. L. & Miron, V. E. Microglia: origins, homeostasis, and roles in myelin repair. Curr. Opin. Neurobiol. 47, 113–120 (2017). · DOI
  78. Lloyd, A. F. & Miron, V. E. Cellular and molecular mechanisms underpinning macrophage activation during remyelination. Front. Cell Dev. Biol. 21, 60 (2016).
  79. Redford, E. J., Kapoor, R. & Smith, K. J. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 120, 2149–2157 (1997). · DOI
  80. Cibelli, M. et al. Role of interleukin-1beta in postoperative cognitive dysfunction. Ann. Neurol. 68, 360–368 (2010). · DOI
  81. Williamson, L. L. & Bilbo, S. D. Chemokines and the hippocampus: a new perspective on hippocampal plasticity and vulnerability. Brain Behav. Immun. 30, 186–194 (2013). · DOI
  82. Di Filippo, M. et al. Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Brain Res. 1621, 205–213 (2015). · DOI
  83. Di Filippo, M. et al. Effects of central and peripheral inflammation on hippocampal synaptic plasticity. Neurobiol. Dis. 52, 229–236 (2013). · DOI
  84. Kim, D. Y. et al. Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis. PLOS ONE 7, e35476 (2012).
  85. Mosayebi, G., Soleyman, M. R., Khalili, M., Mosleh, M. & Palizvan, M. R. Changes in synaptic transmission & long-term potentiation induction as a possible mechanism for learning disability in an animal model of multiple sclerosis. Int. Neurourol. J. 20, 26–32 (2016). · DOI
  86. Prochnow, N., Gold, R. & Haghikia, A. An electrophysiologic approach to quantify impaired synaptic transmission and plasticity in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 264, 48–53 (2013). · DOI
  87. Nisticò, R. et al. Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis. PLOS ONE 8, e54666 (2013). · DOI
  88. Novkovic, T., Shchyglo, O., Gold, R. & Manahan-Vaughan, D. Hippocampal function is compromised in an animal model of multiple sclerosis. Neuroscience 309, 100–112 (2015). · DOI
  89. Planche, V. et al. Selective dentate gyrus disruption causes memory impairment at the early stage of experimental multiple sclerosis. Brain Behav. Immun. 60, 240–254 (2017). · DOI
  90. Ajami, B., Bennett, J. L., Krieger, C., McNagny, K. M. & Rossi, F. M. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat. Neurosci. 14, 1142–1149 (2011). · DOI · Paper page
  91. Gardoni, F. et al. Decreased NR2B subunit synaptic levels cause impaired long-term potentiation but not long-term depression. J. Neurosci. 29, 669–677 (2009). · DOI
  92. Kamsler, A. & Segal, M. Hydrogen peroxide modulation of synaptic plasticity. J. Neurosci. 23, 269–276 (2003). · DOI
  93. Minagar, A. et al. The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects. Neurology 80, 210–219 (2013). This comprehensive manuscript discusses the role of thalamic damage in MS. · DOI
  94. Kipp, M. et al. Thalamus pathology in multiple sclerosis: from biology to clinical application. Cell. Mol. Life Sci. 72, 1127–1147 (2015). · DOI
  95. Parmar, K. et al. The role of the cerebellum in multiple sclerosis-150 years after Charcot. Neurosci. Biobehav Rev. 89, 85–98 (2018). This article presents a review on cerebellar involvement in MS, including its potential role in MS-related cognitive impairment. · DOI
  96. Benedict, R. H. et al. Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients. Mult. Scler. 19, 1478–1484 (2013). · DOI
  97. Bisecco, A. et al. Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: a multicenter study. Hum. Brain Mapp. 36, 2809–2825 (2015). · DOI
  98. Bisecco, A. et al. Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume. Brain Imag. Behav. 12, 20–28 (2017). · DOI
  99. Ruet, A. et al. Information processing speed impairment and cerebellar dysfunction in relapsing-remitting multiple sclerosis. J. Neurol. Sci. 347, 246–250 (2014). · DOI
  100. Allen, G., Buxton, R. B., Wong, E. C. & Courchesne, E. Attentional activation of the cerebellum independent of motor involvement. Science 275, 1940–1943 (1997). · DOI
  101. Buckner, R. L., Krienen, F. M., Castellanos, A., Diaz, J. C. & Yeo, B. T. The organization of the human cerebellum estimated by intrinsic functional connectivity. J. Neurophysiol. 106, 2322–2345 (2011). · DOI · Paper page
  102. D’Ambrosio, A. et al. Cerebellar contribution to motor and cognitive performance in multiple sclerosis: an MRI sub-regional volumetric analysis. Mult. Scler. 23, 1194–1203 (2017). · DOI
  103. Moroso, A. et al. Posterior lobules of the cerebellum and information processing speed at various stages of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 88, 146–151 (2017). · DOI
  104. Houtchens, M. K. et al. Thalamic atrophy and cognition in multiple sclerosis. Neurology 69, 1213–1223 (2007). · DOI
  105. Schoonheim, M. M. et al. Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis. Neurology 84, 776–783 (2015). · DOI
  106. DeLuca, J., Chelune, G. J., Tulsky, D. S., Lengenfelder, J. & Chiaravalloti, N. D. Is speed of processing or working memory the primary information processing deficit in multiple sclerosis? J. Clin. Exp. Neuropsychol. 26, 550–562 (2004). · DOI
  107. Costa, S. L., Genova, H. M., DeLuca, J. & Chiaravalloti, N. D. Information processing speed in multiple sclerosis: past, present, and future. Mult. Scler. 23, 772–789 (2017). · DOI
  108. Kern, K. C. et al. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis. Neuroimage Clin. 8, 440–447 (2014). · DOI
  109. Foong, J. et al. Executive function in multiple sclerosis. The role of frontal lobe pathology. Brain. 120, 15–26 (1997). · DOI
  110. Foong, J. et al. Correlates of executive function in multiple sclerosis: the use of magnetic resonance spectroscopy as an index of focal pathology. J. Neuropsychiatry Clin. Neurosci. 11, 45–50 (1999). · DOI
  111. Muhlert, N. et al. Diffusion MRI-based cortical complexity alterations associated with executive function in multiple sclerosis. J. Magn. Reson. Imaging 38, 54–63 (2013). · DOI
  112. Muhlert, N. et al. The grey matter correlates of impaired decision-making in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 86, 530–536 (2015). · DOI
  113. Weygandt, M. et al. Brain activity, regional gray matter loss, and decision-making in multiple sclerosis. Mult. Scler. 24, 1163–1173 (2017). · DOI
  114. Koini, M. et al. Correlates of executive functions in multiple sclerosis based on structural and functional MR imaging: insights from a multicenter study. Radiology 280, 869–879 (2016). · DOI
  115. Leavitt, V. M., Lengenfelder, J., Moore, N. B., Chiaravalloti, N. D. & DeLuca, J. The relative contributions of processing speed and cognitive load to working memory accuracy in multiple sclerosis. J. Clin. Exp. Neuropsychol. 33, 580–586 (2011). · DOI
  116. Lengenfelder, J. et al. Processing speed interacts with working memory efficiency in multiple sclerosis. Arch. Clin. Neuropsychol. 21, 229–238 (2006). · DOI
  117. Macniven, J. A. et al. Stroop performance in multiple sclerosis: information processing, selective attention, or executive functioning? J. Int. Neuropsychol. Soc. 14, 805–814 (2008). · DOI
  118. Henry, J. D., von Hippel, W., Molenberghs, P., Lee, T. & Sachdev, P. S. Clinical assessment of social cognitive function in neurological disorders. Nat. Rev. Neurol. 12, 28–39 (2016). · DOI · Paper page
  119. Chalah, M. A. et al. Theory of mind in multiple sclerosis: a neuropsychological and MRI study. Neurosci. Lett. 658, 108–113 (2017). · DOI
  120. Mesulam, M. M. (ed.). Principles of Behavioral and Cognitive Neurology 2nd edn (Oxford Univ. Press, 2000). · DOI · Paper page
  121. Lezak, M. D., Howieson, D. B., Loring, D. W. & Fischer, J. S. Neuropsychological Assessment 4th edn (Oxford Univ. Press, 2004).
  122. Sumowski, J. F. et al. Cognition in multiple sclerosis: state of the field and priorities for the future. Neurology 90, 278–288 (2018). · DOI
  123. Benedict, R. H. et al. Validity of the symbol digit modalities test as a cognition performance outcome measure for multiple sclerosis. Mult. Scler. 23, 721–733 (2017). · DOI
  124. Benedict, R. H. et al. Validity of the minimal assessment of cognitive function in multiple sclerosis. (MACFIMS). J. Int. Neuropsychol. Soc. 12, 549–558 (2006). · DOI
  125. Rocca, M. A. et al. Hippocampal-DMN disconnectivity in MS is related to WM lesions and depression. Hum. Brain Mapp. 36, 5051–5063 (2015). · DOI
  126. Rossi, F. et al. Relevance of brain lesion location to cognition in relapsing multiple sclerosis. PLOS ONE 7, e44826 (2012).
  127. Mandolesi, G. et al. Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis. Nat. Rev. Neurol. 11, 711–724 (2015). · DOI
  128. Stampanoni Bassi, M. et al. Neurophysiology of synaptic functioning in multiple sclerosis. Clin. Neurophysiol. 128, 1148–1157 (2017). · DOI
  129. Mori, F. et al. Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis. Neuropsychopharmacology 36, 559–568 (2011). · DOI
  130. Mancini, A. et al. Hippocampal neuroplasticity and inflammation: relevance for multiple sclerosis. Mult. Scler. Dem. Dis. 2, 2 (2017).
  131. Giovannoni, G. et al. Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses. Mult. Scler. Relat. Disord. 12, 70–78 (2017). · DOI
  132. Correale, J., Gaitán, M. I., Ysrraelit, M. C. & Fiol, M. P. Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain 140, 527–546 (2017).
  133. Hemmer, B., Kerschensteiner, M. & Korn, T. Role of the innate and adaptive immune responses in the course of multiple sclerosis. Lancet Neurol. 14, 406–419 (2015). · DOI
  134. Lassmann, H. & Bradl, M. Multiple sclerosis: experimental models and reality. Acta Neuropathol. 133, 223–244 (2017). · DOI · Paper page
  135. Baxter, A. G. The origin and application of experimental autoimmune encephalomyelitis. Nat. Rev. Immunol. 7, 904–912 (2007). · DOI
  136. Baker, D., Gerritsen, W., Rundle, J. & Amor, S. Critical appraisal of animal models of multiple sclerosis. Mult. Scler. 17, 647–657 (2011). · DOI
  137. Sriram, S. & Steiner, I. Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Ann. Neurol. 58, 939–945 (2005). · DOI
  138. Felten, D. L. & Shetty, A. N. Atlante di Neuroscienze di Netter [Italian] 2nd edn (eds Gulisano, M., Falcieri, E. & Cappello, F.) 298 (Elsevier, 2010).

Cited by

Sorted by citations

See all 205

Metadata

Authors
Di Filippo, M., Portaccio, E., Mancini, A., & Calabresi, P.
Venue
Nature Reviews Neuroscience
Publisher
Springer Science and Business Media LLC
Published
2018-08-29
Volume
19
Issue
10
Pages
599-609
ISSN
  • 1471-003X
  • 1471-0048
DOI
10.1038/s41583-018-0053-9
Cited by
205
References
11
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review